We have studied the dynamics of nuclear translocation during nuclear factor B activation by using a p65(RELA)-enhanced green fluorescent protein (EGFP) fusion construct. Quantitation of expression levels indicates that EGFPRELA can be detected at physiological concentrations of about 60,000 molecules per cell. Stimulation of transfected fibroblasts with interleukin (IL)-1 caused nuclear translocation of EGFPRELA, typically resulting in a 30-fold increase in nuclear protein at maximum induction and a concomitant 20% decrease in cytoplasmic levels. The response of individual cells to IL-1 was graded, and the kinetics of nuclear translocation were dependent on the dose of IL-1 and the level of EGFPRELA expression. The rate of nuclear uptake was saturable, and the time lag for uptake increased at higher EGFPRELA expression levels. Furthermore, nuclear translocation was reduced at less than saturating doses of IL-1 suggesting that the pathway is limited by incoming signals. The response to IL-1 was biphasic, demonstrating a decline in nuclear import rate at expression levels above three to four times endogenous. This correlated with the anti-apoptotic function of EGFP-RELA which was more prominent at low expression levels and demonstrated successively less protection at higher levels. In comparison, transfection of p50 had no effect on the level of apoptosis and demonstrated some toxicity in combination with EGFPRELA.Inflammatory responses involve the rapid and coordinated activation of a diverse set of genes. This activation is initiated by a variety of agonists including bacterial lipopolysaccharide, phorbol esters, IL-1, 1 and tumor necrosis factor-␣ (1-6) and in addition by stress (7,8) and cell adhesion (9, 10). These agents dynamically regulate cytoplasmic signal transduction networks dependent on developmental stage-and cell type-specific expression of extracellular receptors and intracellular adaptor proteins. A major downstream target of these networks is the NF-B family of transcription factors (11-15) that has been shown to possess both pro-and anti-apoptotic functions dependent on cell type (16, 17).NF-B transcription factors are hetero-or homodimers of a family of related proteins characterized by the Rel homology domain. They form two subfamilies, those containing activation domains (p65-RELA, RELB, and c-REL) and those lacking activation domains (p50, p52) (18). The prototypical NF-B is a heterodimer of p65 (RELA) and p50 (NF-B1). Additionally, a family of at least seven inhibitory subunits, IB, characterized by multiple ankyrin-like repeats has been described (19,20). The paradigm for NF-B activation is nuclear translocation of p50 (NF-B1)/p65 (RELA) heterodimers following IB␣ degradation. Specifically, IB␣ binds to these dimers, thereby masking their nuclear localization signals and preventing nuclear import. Activation of cytoplasmic signal transduction pathways results in the phosphorylation and then ubiquitination and subsequent degradation of IB␣, allowing the dimers to move to the nucleus w...